To the Editor-In response to the editorial by Williams et al, the American Society of Colon and Rectal Surgeons Clinical Practice Guidelines Committee stands by our statement on pulmonary metastectomy in stage 4 colon cancer. Although the evidence on this subject is limited and with conflicting results, we believe we have presented that evidence fairly. We cited 3 large observational studies from high-impact journals citing positive results with pulmonary metastectomy and balanced this discussion by showing the negative results of the Pulmonary Metastasectomy in Colorectal Cancer study, stating that "nonsurgical treatment should also be considered." [1][2][3][4][5] Williams et al cite the limitations of the Pulmonary Metastasectomy in Colorectal Cancer trial in their editorial. It is important to note that there is no large, randomized trial with well-matched patient cohorts on this topic indicating some persistent clinical equipoise. Clinical practice guidelines are meant to summarize the currently available clinical literature on a given topic. They are not intended to provide guidance for all patients under a given circumstance. The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system of recommendations allows us to help the reader understand how strong the literature is on a given topic. A "2B" recommendation is a weak recommendation based on moderate-quality evidence. Moderate-quality evidence is randomized controlled trials with important limitations or strong evidence from observational studies. The benefits are closely balanced with the risks and burdens. 6 The weak recommendation indicates that the best action may differ depending on circumstances.